Spending Bill Raises Medical Product Safety Funding by $113.2 Million

The House passed an omnibus spending bill on March 22 that boosts FDA funding for medical product safety activities by $113.2 million, including a one-time payment of $94 million to expand FDA’s surveillance efforts at international mail facilities to address the opioid crisis.
Source: Drug GMP Report